Research Article

Integrated Brain Metabolomics and Network Pharmacology Analysis to Reveal the Improvement Effect of Bai Chan Ting on Parkinson’s Disease

Table 2

The identifification of potential biomarkers.

No.ESI
mode
MetabolitesVIPMeasured mass(Da)Calculated mass (Da)Error m/z (ppm)RT
(s)
Control vs
model
trend
Model vs
PT
trend

1NegPhosphocreatine1.5024211.033211.11310.0801362.592
2NegGalactonic acid1.5926196.051196.15530.1043371.962
3NegSuccinate1.4109118.019118.0880.069387.540
4NegAcetyl phosphate1.0908139.936140.03190.0959499.938
5NegL-glutamate1.1974147.046147.12930.0833396.310
6NegL-histidine1.0672155.062155.15460.0926425.167
7NegL-methionine1.0852149.043149.2110.168310.026
8NegN-acetylmannosamine1.4454221.104221.20780.1038356.177
9NegNervonic acid1.1663366.342366.62080.2788125.617
10NegPhosphoenolpyruvate1.0987167.964168.0420.078458.221
11NegProstaglandin E21.0286352.218352.46510.247191.224
12NegTaurocholate1.0506515.285515.7030.418198.837
13NegL-tyrosine1.1096181.066181.18850.1225302.726
14Pos1-Methylhistidine1.6921169.091169.18110.0901352.570
15PosAlpha-linolenic acid1.0387279.257278.4296-0.827433.231
16PosArgininosuccinic acid1.2715290.130290.27310.1431459.555
17PosDopamine1.0788153.075153.17840.1034291.703
18PosGlutathione1.6425307.090307.320.23448.013
19PosL-arginine2.2639174.118174.2010.083393.471
20PosL-cysteine1.9694122.051121.158-0.893227.686
21PosL-proline1.4740115.070115.13050.0605300.404
22PosL-pyroglutamic acid1.2330130.075129.114-0.961392.084
23PosProstaglandin I21.2633352.230352.46510.2351202.732
24Pos4-Guanidinobutyric acid1.4416145.091145.15970.0687349.299
25Pos4-Aminobutyric acid1.9662103.069103.11980.0508362.801